Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rudolf Hoermann

Showing results (41-50 of 97) with videos related to

Pageof 10
Sort By:
Journal of Hepatology|June 18, 2016
Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: A randomised controlled trialMarie Sinclair, Mathis Grossmann, Rudolf Hoermann, et al.
European Journal of Endocrinology|February 22, 2023
Effects of oestradiol treatment on hot flushes in men undergoing androgen deprivation therapy for prostate cancer: a randomised placebo-controlled trialNicholas Russell, Rudolf Hoermann, Ada S Cheung, et al.
Plos One|November 21, 2017
Advances in applied homeostatic modelling of the relationship between thyrotropin and free thyroxineRudolf Hoermann, John Edward Maurice Midgley, Rolf Larisch, et al.
Trials|April 22, 2022
Tolvaptan versus fluid restriction in acutely hospitalised patients with moderate-profound hyponatraemia (TVFR-HypoNa): design and implementation of an open-label randomised trialAnnabelle M Warren, Mathis Grossmann, Rudolf Hoermann, et al.
Therapeutic Advances in Endocrinology and Metabolism|March 20, 2023
The role of supporting and disruptive mechanisms of FT3 homeostasis in regulating the hypothalamic-pituitary-thyroid axisRudolf Hoermann, Mark J Pekker, John E M Midgley, et al.
Thyroid : Official Journal of the American Thyroid Association|September 29, 2005
Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' diseaseBeate Quadbeck, Rudolf Hoermann, Ulla Roggenbuck, et al.
Frontiers in Endocrinology|November 16, 2020
The Two Faces of Janus: Why Thyrotropin as a Cardiovascular Risk Factor May Be an Ambiguous TargetJohannes Wolfgang Dietrich, Rudolf Hoermann, John E M Midgley, et al.
BMC Endocrine Disorders|April 20, 2019
Time for a reassessment of the treatment of hypothyroidismJohn E M Midgley, Anthony D Toft, Rolf Larisch, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 20, 2016
Low serum testosterone is associated with adverse outcome in men with cirrhosis independent of the model for end-stage liver disease scoreMarie Sinclair, Paul J Gow, Mathis Grossmann, et al.
Transplantation|June 12, 2014
Low-serum testosterone levels pre-liver transplantation are associated with reduced rates of early acute allograft rejection in menMarie Sinclair, Peter W Angus, Paul J Gow, et al.
Pageof 10

Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
Journal of Hepatology|June 18, 2016
Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: A randomised controlled trialMarie Sinclair, Mathis Grossmann, Rudolf Hoermann, et al.
European Journal of Endocrinology|February 22, 2023
Effects of oestradiol treatment on hot flushes in men undergoing androgen deprivation therapy for prostate cancer: a randomised placebo-controlled trialNicholas Russell, Rudolf Hoermann, Ada S Cheung, et al.
Plos One|November 21, 2017
Advances in applied homeostatic modelling of the relationship between thyrotropin and free thyroxineRudolf Hoermann, John Edward Maurice Midgley, Rolf Larisch, et al.
Trials|April 22, 2022
Tolvaptan versus fluid restriction in acutely hospitalised patients with moderate-profound hyponatraemia (TVFR-HypoNa): design and implementation of an open-label randomised trialAnnabelle M Warren, Mathis Grossmann, Rudolf Hoermann, et al.
Therapeutic Advances in Endocrinology and Metabolism|March 20, 2023
The role of supporting and disruptive mechanisms of FT3 homeostasis in regulating the hypothalamic-pituitary-thyroid axisRudolf Hoermann, Mark J Pekker, John E M Midgley, et al.
Thyroid : Official Journal of the American Thyroid Association|September 29, 2005
Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' diseaseBeate Quadbeck, Rudolf Hoermann, Ulla Roggenbuck, et al.
Frontiers in Endocrinology|November 16, 2020
The Two Faces of Janus: Why Thyrotropin as a Cardiovascular Risk Factor May Be an Ambiguous TargetJohannes Wolfgang Dietrich, Rudolf Hoermann, John E M Midgley, et al.
BMC Endocrine Disorders|April 20, 2019
Time for a reassessment of the treatment of hypothyroidismJohn E M Midgley, Anthony D Toft, Rolf Larisch, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 20, 2016
Low serum testosterone is associated with adverse outcome in men with cirrhosis independent of the model for end-stage liver disease scoreMarie Sinclair, Paul J Gow, Mathis Grossmann, et al.
Transplantation|June 12, 2014
Low-serum testosterone levels pre-liver transplantation are associated with reduced rates of early acute allograft rejection in menMarie Sinclair, Peter W Angus, Paul J Gow, et al.
Pageof 10